174 related articles for article (PubMed ID: 9107546)
1. Kinetics of drug metabolism in rat liver slices. III. Relationship between metabolic clearance and slice uptake rate.
Worboys PD; Bradbury A; Houston JB
Drug Metab Dispos; 1997 Apr; 25(4):460-7. PubMed ID: 9107546
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of drug metabolism in rat liver slices. II. Comparison of clearance by liver slices and freshly isolated hepatocytes.
Worboys PD; Bradbury A; Houston JB
Drug Metab Dispos; 1996 Jun; 24(6):676-81. PubMed ID: 8781785
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of drug metabolism in rat liver slices. Rates of oxidation of ethoxycoumarin and tolbutamide, examples of high- and low-clearance compounds.
Worboys PD; Bradbury A; Houston JB
Drug Metab Dispos; 1995 Mar; 23(3):393-7. PubMed ID: 7628306
[TBL] [Abstract][Full Text] [Related]
4. Metabolite kinetics of ondansetron in rat. Comparison of hepatic microsomes, isolated hepatocytes and liver slices, with in vivo disposition.
Worboys PD; Brennan B; Bradbury A; Houston JB
Xenobiotica; 1996 Sep; 26(9):897-907. PubMed ID: 8893037
[TBL] [Abstract][Full Text] [Related]
5. Prediction of in vivo disposition from in vitro systems: clearance of phenytoin and tolbutamide using rat hepatic microsomal and hepatocyte data.
Ashforth EI; Carlile DJ; Chenery R; Houston JB
J Pharmacol Exp Ther; 1995 Aug; 274(2):761-6. PubMed ID: 7636740
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of drug metabolism in rat liver slices: IV. Comparison of ethoxycoumarin clearance by liver slices, isolated hepatocytes, and hepatic microsomes from rats pretreated with known modifiers of cytochrome P-450 activity.
Carlile DJ; Hakooz N; Houston JB
Drug Metab Dispos; 1999 Apr; 27(4):526-32. PubMed ID: 10101148
[TBL] [Abstract][Full Text] [Related]
7. Empirical validation of a rat in vitro organ slice model as a tool for in vivo clearance prediction.
de Graaf IA; de Kanter R; de Jager MH; Camacho R; Langenkamp E; van de Kerkhof EG; Groothuis GM
Drug Metab Dispos; 2006 Apr; 34(4):591-9. PubMed ID: 16415126
[TBL] [Abstract][Full Text] [Related]
8. Rate-limiting steps in hepatic drug clearance: comparison of hepatocellular uptake and metabolism with microsomal metabolism of saquinavir, nelfinavir, and ritonavir.
Parker AJ; Houston JB
Drug Metab Dispos; 2008 Jul; 36(7):1375-84. PubMed ID: 18426953
[TBL] [Abstract][Full Text] [Related]
9. The biotransformation of the ergot derivative CQA 206-291 in human, dog, and rat liver slice cultures and prediction of in vivo plasma clearance.
Vickers AE; Connors S; Zollinger M; Biggi WA; Larrauri A; Vogelaar JP; Brendel K
Drug Metab Dispos; 1993; 21(3):454-9. PubMed ID: 8100501
[TBL] [Abstract][Full Text] [Related]
10. Prediction of the hepatic and renal clearance of transporter substrates in rats using in vitro uptake experiments.
Watanabe T; Maeda K; Kondo T; Nakayama H; Horita S; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2009 Jul; 37(7):1471-9. PubMed ID: 19364828
[TBL] [Abstract][Full Text] [Related]
11. Development of a simple incubation system for metabolism studies with precision-cut liver slices.
Dogterom P
Drug Metab Dispos; 1993; 21(4):699-704. PubMed ID: 8104130
[TBL] [Abstract][Full Text] [Related]
12. The use of sandwich-cultured rat hepatocytes to determine the intrinsic clearance of compounds with different extraction ratios: 7-ethoxycoumarin and warfarin.
Treijtel N; van Helvoort H; Barendregt A; Blaauboer BJ; van Eijkeren JC
Drug Metab Dispos; 2005 Sep; 33(9):1325-32. PubMed ID: 15951450
[TBL] [Abstract][Full Text] [Related]
13. Utility of rat liver slices to estimate hepatic clearance for application in physiologically based pharmacokinetic modeling: a study with tolbutamide, a compound with low extraction efficiency.
Haenen B; Rompelberg C; van Twillert K; Hamzink M; Dormans J; van Eijkeren J
Drug Metab Dispos; 2002 Mar; 30(3):307-13. PubMed ID: 11854150
[TBL] [Abstract][Full Text] [Related]
14. Kinetic study of the hepatobiliary transport of a new prostaglandin receptor agonist.
Imawaka H; Sugiyama Y
J Pharmacol Exp Ther; 1998 Mar; 284(3):949-57. PubMed ID: 9495854
[TBL] [Abstract][Full Text] [Related]
15. In vivo disposition of caffeine predicted from hepatic microsomal and hepatocyte data.
Hayes KA; Brennan B; Chenery R; Houston JB
Drug Metab Dispos; 1995 Mar; 23(3):349-53. PubMed ID: 7628300
[TBL] [Abstract][Full Text] [Related]
16. Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol.
Obach RS
Drug Metab Dispos; 1997 Dec; 25(12):1359-69. PubMed ID: 9394025
[TBL] [Abstract][Full Text] [Related]
17. Sigmoidal kinetics of CYP3A substrates: an approach for scaling dextromethorphan metabolism in hepatic microsomes and isolated hepatocytes to predict in vivo clearance in rat.
Witherow LE; Houston JB
J Pharmacol Exp Ther; 1999 Jul; 290(1):58-65. PubMed ID: 10381760
[TBL] [Abstract][Full Text] [Related]
18. A convenient in vitro screening method for predicting in vivo drug metabolic clearance using isolated hepatocytes suspended in serum.
Shibata Y; Takahashi H; Ishii Y
Drug Metab Dispos; 2000 Dec; 28(12):1518-23. PubMed ID: 11095592
[TBL] [Abstract][Full Text] [Related]
19. Establishment of rat precision-cut fibrotic liver slice technique and its application in verapamil metabolism.
Guo Y; Wang H; Zhang C
Clin Exp Pharmacol Physiol; 2007; 34(5-6):406-13. PubMed ID: 17439408
[TBL] [Abstract][Full Text] [Related]
20. Prediction of the pharmacokinetics of atorvastatin, cerivastatin, and indomethacin using kinetic models applied to isolated rat hepatocytes.
Paine SW; Parker AJ; Gardiner P; Webborn PJ; Riley RJ
Drug Metab Dispos; 2008 Jul; 36(7):1365-74. PubMed ID: 18426955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
